The DOI matches its Crossref record; 201 of the 201 references it cites were found in a registry or an index.
Transcriptional control of human p53-regulated genes
Abstract
The p53 protein regulates the transcription of many different genes in response to a wide variety of stress signals. Following DNA damage, p53 regulates key processes, including DNA repair, cell-cycle arrest, senescence and apoptosis, in order to suppress cancer. This Analysis article provides an overview of the current knowledge of p53-regulated genes in these pathways and others, and the mechanisms of their regulation. In addition, we present the most comprehensive list so far of human p53-regulated genes and their experimentally validated, functional binding sites that confer p53 regulation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The tumor suppressor p53 functions primarily as a transcription factor.”
From Census and evaluation of p53 target genes (2017) · cites this paper as [5]
In the citing paper
“The prevailing function of the p53 tumor suppressor is the transcriptional control of target genes that regulate numerous cellular processes, including cell cycle and apoptosis.5, 6”
From Census and evaluation of p53 target genes (2017) · cites this paper as [5]
In the citing paper
“p53 is an crucial tumor suppressor that is mutated in more than 50% of human cancers”
From USP10 Regulates p53 Localization and Stability by Deubiquitinating p53 (2010) · cites this paper as Riley et al., 2008
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Self-citationVogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“These include several types of DNA damage: telomere shortening, hypoxia, mitotic spindle damage, heat or cold shock, unfolded proteins, improper ribosomal biogenesis, nutritional deprivation in a transformed cell, and even the activation of some oncogenes by mutatio”
BackgroundSelf-citationEddy, S. R. (1998) · Bioinformatics · doi:10.1093/bioinformatics/14.9.755 · Cited by 5,515
Sequence logos: a new way to display consensus sequences
Schneider, T. D., & Stephens, R. M. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.20.6097 · Cited by 3,354
Durbin, R. M., Eddy, S. R., Krogh, A., & Mitchison, G. (1998) · Cambridge University Press eBooks · doi:10.1017/cbo9780511790492 · Cited by 3,255
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,559 · cited 1×
“On the basis of X-ray crystallography studies of the p53 DNA-binding core domain bound to a p53-RE DNA sequence, the most important bases for interactions with the p53 protein are the central RCWWGY, which come into close contact with the amino acids from the p53 core domai”
BackgroundHistone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1779 · Cited by 2,234
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
Yonish-Rouach, E., Resnftzky, D., Lotem, J., Sachs, L., Kimchi, A., & Oren, M. (1991) · Nature · doi:10.1038/352345a0 · Cited by 2,079
Maximum Entropy Modeling of Short Sequence Motifs with Applications to RNA Splicing Signals
Yeo, G. W.-M., & Burge, C. B. (2004) · Journal of Computational Biology · doi:10.1089/1066527041410418 · Cited by 2,042
Definition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
The p53 pathway: positive and negative feedback loops
Harris, S. L., & Levine, A. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208615 · Cited by 1,967
Self-citationHidden Markov Models in Computational Biology
Krogh, A., Brown, M., Mian, S. I., Sjölander, K. V., & Haussler, D. H. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1104 · Cited by 1,948
DNA binding sites: representation and discovery
Stormo, G. D. (2000) · Bioinformatics · doi:10.1093/bioinformatics/16.1.16 · Cited by 1,519
Shukla, S., Mishra, B., Avashthi, H., & Chandra, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-89775-4.00003-1 · Cited by 1,514
Assessing computational tools for the discovery of transcription factor binding sites
Tompa, M., Li, N., Bailey, T. L., Church, G. M., De Moor, B., Eskin, E., Favorov, A. V., Frith, M. C., Fu, Y., Kent, W. J., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1053 · Cited by 1,268
Bond, G. L., Hu, W., Bond, E. E., Robins, H., Lutzker, S. G., Arva, N. C., Bargonetti, J., Bartel, F., Taubert, H., Wuerl, P., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.022 · Cited by 1,265
Self-citationIs a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251
The coordinate regulation of the p53 and mTOR pathways in cells
Feng, Z., Zhang, H., Levine, A. J., & Jin, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502857102 · Cited by 1,235
Self-citationApplied bioinformatics for the identification of regulatory elements
Wasserman, W. W., & Sandelin, A. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1315 · Cited by 1,233
Oda, K., Arakawa, H., Tanaka, T., Matsuda, K., Tanikawa, C., Mori, T., Nishimori, H., Tamai, K., Tokino, T., Nakamura, Y., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00073-8 · Cited by 1,162
A Global Map of p53 Transcription-Factor Binding Sites in the Human Genome
Wei, C.-L., Wu, Q., Vega, V. B., Chiu, K. P., Ng, P., Zhang, T., Shahab, A., Yong, H. C., Fu, Y., Weng, Z., et al. (2006) · Cell · doi:10.1016/j.cell.2005.10.043 · Cited by 1,141
DNA sequence-dependent deformability deduced from protein–DNA crystal complexes
Olson, W. K., Gorin, A. A., Lu, X., Hock, L. M., & Zhurkin, V. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11163 · Cited by 1,039
Interaction of the p53-Regulated Protein Gadd45 with Proliferating Cell Nuclear Antigen
Smith, M. L., Chen, I. T., Zhan, Q., Bae, I., Chen, C.-Y., Gilmer, T. M., Kastan, M. B., O'Connor, P. M., & Fornace, A. J. (1994) · Science · doi:10.1126/science.7973727 · Cited by 946
Oncogenic Forms of p53 Inhibit p53-Regulated Gene Expression
Kern, S. E., Pietenpol, J., Thiagalingam, S., Seymour, A., Kinzler, K. W., & Vogelstein, B. (1992) · Science · doi:10.1126/science.1589764 · Cited by 940
Regulation of PTEN Transcription by p53
Stambolic, V., MacPherson, D. P., Sas, D., Lin, Y., Snow, B., Jang, Y., Benchimol, S., & Mak, T. W. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00323-9 · Cited by 936
A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage
Tanaka, H., Arakawa, H., Yamaguchi, T., Shiraishi, K., Fukuda, S., Matsui, K., Takei, Y., & Nakamura, Y. (2000) · Nature · doi:10.1038/35003506 · Cited by 904
p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
Müller, M., Wilder, S., Bannasch, D., Israeli, D., Lehlbach, K., Li-Weber, M., Friedman, S. L., Galle, P. R., Stremmel, W., Oren, M., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2033 · Cited by 878
Induction of the growth inhibitor IGF-binding protein 3 by p53
Buckbinder, L., Talbott, R. L., Velasco-Miguel, S., Takenaka, I. M., Faha, B., Seizinger, B. R., & Kley, N. (1995) · Nature · doi:10.1038/377646a0 · Cited by 869
Regulation of p53 activity through lysine methylation
Chuikov, S., Kurash, J. K., Wilson, J. R., Xiao, B., Justin, N., Ivanov, G. S., McKinney, K. M., Tempst, P., Prives, C. L., Gamblin, S. J., et al. (2004) · Nature · doi:10.1038/nature03117 · Cited by 846
p63 and p73 are required for p53-dependent apoptosis in response to DNA damage
Flores, E. R., Tsai, K. Y., Crowley, D. G., Sengupta, S., Yang, A., McKeon, F., & Jacks, T. (2002) · Nature · doi:10.1038/416560a · Cited by 815
Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53
Hoffman, W. H., Biade, S., Zilfou, J. T., Chen, J., & Murphy, M. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106643200 · Cited by 811
A Transcriptionally Active DNA-Binding Site for Human p53 Protein Complexes
Funk, W. D., Pak, D. T. S., Karas, R. H., Wright, W. E., & Shay, J. W. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.6.2866 · Cited by 732
Barlev, N. A., Liu, L., Chehab, N. H., Mansfield, K., Harris, K. G., Halazonetis, T. D., & Berger, S. L. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00414-2 · Cited by 710
The ubiquitin ligase COP1 is a critical negative regulator of p53
Dornan, D., Wertz, I. E., Shimizu, H., Arnott, D. P., Frantz, G. D., Dowd, P., Rourke, K. O., Koeppen, H., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02514 · Cited by 700
The Regulation of Exosome Secretion: a Novel Function of the p53 Protein
Yu, X., Harris, S. L., & Levine, A. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4579 · Cited by 688
Self-citationNPAT links cyclin E–Cdk2 to the regulation of replication-dependent histone gene transcriptionPreprint
Zhao, J., Kennedy, B. K., Lawrence, B. D., Barbie, D. A., Matera, A. G., Fletcher, J. A., & Harlow, E. (2000) · Genes & Development · doi:10.1101/gad.827700 · Cited by 665
The P53 pathway: what questions remain to be explored?
Levine, A. J., Hu, W., & Feng, Z. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401910 · Cited by 661
Self-citationFeng, Z., Hu, W., de Stanchina, E., Teresky, A. K., Jin, S., Lowe, S., & Levine, A. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4149 · Cited by 633
Self-citationAnalysis of p53-regulated gene expression patterns using oligonucleotide arraysPreprint
Zhao, R., Gish, K., Murphy, M. E., Yin, Y., Notterman, D. A., Hoffman, W. H., Tom, E., Mack, D. H., & Levine, A. J. (2000) · Genes & Development · doi:10.1101/gad.14.8.981 · Cited by 632
Self-citationSynergistic activation of transcription by CBP and p53
Gu, W., Shi, X.-L., & Roeder, R. G. (1997) · Nature · doi:10.1038/42972 · Cited by 599
Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.
El‐Deiry, W. S., Tokino, T., Waldman, T. A., Oliner, J., Velculescu, V. E., Burrell, M., HILL, D. E., Healy, E., Rees, J. L., & Hamilton, S. R. (1995) · PubMed · Cited by 582
Wild-type p53 binds to the TATA-binding protein and represses transcription.
Seto, E., Usheva, A., Zambetti, G. P., Momand, J. A., Horikoshi, N., Weinmann, R. S., Levine, A. J., & Shenk, T. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12028 · Cited by 504
Self-citationEllisen, L. W., Ramsayer, K. D., Johannessen, C. M., Yang, A., Beppu, H., Minda, K., Oliner, J. D., McKeon, F., & Haber, D. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00706-2 · Cited by 474
p53 regulates maternal reproduction through LIF
Hu, W., Feng, Z., Teresky, A. K., & Levine, A. J. (2007) · Nature · doi:10.1038/nature05993 · Cited by 456
Self-citationMurphy, M. E., Ahn, J., Walker, K. K., Hoffman, W. H., Evans, R. M., Levine, A. J., & George, D. L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2490 · Cited by 455
Self-citationEspinosa, J. M., & Emerson, B. M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00283-0 · Cited by 440
p53 Transcriptional Activation Mediated by Coactivators TAF II 40 and TAF II 60
Thut, C. J., Chen, J.-L., Klemm, R. D., & Tjian, R. (1995) · Science · doi:10.1126/science.7809597 · Cited by 439
BID regulation by p53 contributes to chemosensitivity
Sax, J. K., Fei, P., Murphy, M. E., Bernhard, E., Korsmeyer, S. J., & El-Deiry, W. S. (2002) · Nature Cell Biology · doi:10.1038/ncb866 · Cited by 420
Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo
Luo, J., Li, M., Tang, Y., Laszkowska, M., Roeder, R. G., & Gu, W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308762101 · Cited by 419
Di Agostino, S., Strano, S., Emiliozzi, V., Zerbini, V., Mottolese, M., Sacchi, A., Blandino, G., & Piaggio, G. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.013 · Cited by 418
Specificity, free energy and information content in protein–DNA interactions
Stormo, G. D., & Fields, D. S. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01187-6 · Cited by 367
Takimoto, R., & El-Deiry, W. S. (2000) · Oncogene · doi:10.1038/sj.onc.1203489 · Cited by 360
Pidd, a new death-domain–containing protein, is induced by p53 and promotes apoptosis
Lin, Y., Ma, W., & Benchimol, S. (2000) · Nature Genetics · doi:10.1038/79102 · Cited by 359
Inhibition of Cyclooxygenase-2 Gene Expression by p53
Subbaramaiah, K., Altorki, N. K., Chung, W. J., MESTRE, J. R., Sampat, A., & Dannenberg, A. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10911 · Cited by 355
p53DINP1, a p53-Inducible Gene, Regulates p53-Dependent Apoptosis
Okamura, S., Arakawa, H., Tanaka, T., Nakanishi, H., Ng, C. C., Taya, Y., Monden, M., & Nakamura, Y. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00284-2 · Cited by 352
Yang, G., Rosen, D. G., Zhang, Z., Bast, R. C., Mills, G. B., Colacino, J. A., Mercado-Uribe, I., & Liu, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605752103 · Cited by 341
Activation of the p53 tumor suppressor protein
Vousden, K. H. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00035-5 · Cited by 337
PML Is a Direct p53 Target that Modulates p53 Effector Functions
de Stanchina, E., Querido, E., Narita, M., Davuluri, R. V., Pandolfi, P. P., Ferbeyre, G., & Lowe, S. W. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00062-0 · Cited by 312
The p53MH algorithm and its application in detecting p53-responsive genes
Hoh, J., Jin, S. V., Parrado, T., Edington, J., Levine, A. J., & Ott, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132268899 · Cited by 295
Self-citationRegulation of the Human hsp70 Promoter by p53
Agoff, S. N., Hou, J., Linzer, D. I., & Wu, B. (1993) · Science · doi:10.1126/science.8418500 · Cited by 292
p53 Regulates the Expression of the Tumor Suppressor Gene Maspin
Zou, Z., Gao, C., Nagaich, A. K., Connell, T., Saito, S., Moul, J. W., Seth, P. K., Appella, E., & Srivastava, S. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6051 · Cited by 277
A functional p53-responsive intronic promoter is contained within the human mdm2 gene
Zauberman, A., Flusberg, D., Haupt, Y., Barak, Y., & Oren, M. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.14.2584 · Cited by 276
A polymorphic microsatellite that mediates induction of PIG3 by p53
Contente, A., Dittmer, A., Koch, M. C., Roth, J., & Dobbelstein, M. (2002) · Nature Genetics · doi:10.1038/ng836 · Cited by 274
Bian, J., & Sun, Y. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6330 · Cited by 274
Tan, M., Wang, Y., Guan, K., & Sun, Y. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.109 · Cited by 257
Velasco-Miguel, S., Buckbinder, L., Jean, P., Gelbert, L., Talbott, R. L., Laidlaw, J. L., Seizinger, B. R., & Kley, N. (1999) · Oncogene · doi:10.1038/sj.onc.1202274 · Cited by 252
Saramaki, A. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj460 · Cited by 252
ASC is a Bax adaptor and regulates the p53–Bax mitochondrial apoptosis pathway
Ohtsuka, T., Ryu, H., Minamishima, Y. A., Macip, S., Sagara, J., Nakayama, K. I., Aaronson, S. A., & Lee, S. W. (2004) · Nature Cell Biology · doi:10.1038/ncb1087 · Cited by 243
p53 alterations in human cancer: more questions than answers
Soussi, T. (2007) · Oncogene · doi:10.1038/sj.onc.1210280 · Cited by 236
Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth
Fei, P., Wang, W., Kim, S.-H., Wang, S., Burns, T. F., Sax, J. K., Buzzai, M., Dicker, D. T., McKenna, W. G., Bernhard, E. J., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.012 · Cited by 236
p21/CDKN1A Mediates Negative Regulation of Transcription by p53
Löhr, K., Möritz, C., Contente, A., & Dobbelstein, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212517200 · Cited by 227
A Biophysical Approach to Transcription Factor Binding Site DiscoveryPreprint
Djordjević, M., Sengupta, A. M., & Shraiman, B. I. (2003) · Genome Research · doi:10.1101/gr.1271603 · Cited by 226
Potential role for Cathepsin D in p53-dependent tumor suppression and chemosensitivity
Wu, G. S., Säftig, P., Peters, C., & El‐Deiry, W. S. (1998) · Oncogene · doi:10.1038/sj.onc.1201755 · Cited by 226
Targets and mechanisms for the regulation of translation in malignant transformation
Clemens, M. J. (2004) · Oncogene · doi:10.1038/sj.onc.1207544 · Cited by 225
Kanaya, T., Kyo, S., Hamada, K., Takakura, M., Kitagawa, Y., Harada, H., & Inoue, M. (2000) · PubMed · Cited by 222
NDRG1 Is Necessary for p53-dependent Apoptosis
Stein, S., Thomas, E. K., Herzog, B., Westfall, M. D., Rocheleau, J. V., Jackson, R. S., Wang, M., & Liang, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400386200 · Cited by 220
Burns, T. F., Fei, P., Scata, K. A., Dicker, D. T., & El‐Deiry, W. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5556-5571.2003 · Cited by 220
Comparative Binding of p53 to its Promoter and DNA Recognition Elements
Weinberg, R. L., Veprintsev, D. B., Bycroft, M., & Fersht, A. R. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.03.014 · Cited by 211
Direct p53 Transcriptional Repression: In Vivo Analysis of CCAAT-Containing G2/M Promoters
Imbriano, C., Gurtner, A., Cocchiarella, F., Agostino, S. D., Basile, V., Gostissa, M., Dobbelstein, M., Sal, G. D., Piaggio, G., & Mantovani, R. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.9.3737-3751.2005 · Cited by 209
Liu, G., & Chen, X. (2002) · Oncogene · doi:10.1038/sj.onc.1205862 · Cited by 207
Truant, R., Xiao, H., Ingles, C. J., & Greenblatt, J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53769-8 · Cited by 203
Modeling dependencies in protein-DNA binding sites
Barash, Y., Elidan, G., Friedman, N., & Kaplan, T. (2003) · Research in Computational Molecular Biology · doi:10.1145/640075.640079 · Cited by 203
Inga, A., Storici, F., Darden, T. A., & Resnick, M. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8612-8625.2002 · Cited by 195
Wild‐type p53 adopts a ‘mutant’‐like conformation when bound to DNA.
Halazonetis, T. D., Davis, L. J., & Kandil, A. N. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05743.x · Cited by 193
APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis.
Robles, A. I., Bemmels, N. A., Foraker, A. B., & Harris, C. C. (2001) · PubMed · Cited by 190
Transcriptional Activation of the Human Epidermal Growth Factor Receptor Promoter by Human p53
Ludes-Meyers, J. H., Subler, M. A., Shivakumar, C. V., Muñoz, R. M., Jiang, P., Bigger, J. E., Brown, D. R., Deb, S. P., & Deb, S. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6009 · Cited by 185
p53 Upregulates Death Receptor 4 Expression through an Intronic p53 Binding Site
Liu, X., Yue, P., Khuri, F. R., & Sun, S.-Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1195 · Cited by 184
Mirza, A., Wu, Q. J., Wang, L., McClanahan, T., Bishop, W. R., Gheyas, F., Ding, W., Hutchins, B., Hockenberry, T., Kirschmeier, P. T., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206477 · Cited by 183
Nakagawa, T., Takahashi, M., Ozaki, T., Watanabe, K., Todo, S., Mizuguchi, H., Hayakawa, T., & Nakagawara, A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2575-2585.2002 · Cited by 177
p53 tagged sites from human genomic DNA
Tokino, T., Thiagalingam, S., El‐Deiry, W. S., Waldman, T. A., Kinzler, K. W., & Vogelstein, B. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.9.1537 · Cited by 177
p53-Mediated Repression of Alpha-Fetoprotein Gene Expression by Specific DNA Binding
Lee, K. C., Crowe, A. J., & Barton, M. C. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1279 · Cited by 175
DNA Damage-Induced Downregulation of Cdc25C Is Mediated by p53 via Two Independent Mechanisms
Clair, S. S., Giono, L. E., Varmeh, S., Resnick‐Silverman, L., Liu, W.-J., Padi, A., Dastidar, J., DaCosta, A., Mattia, M., & Manfredi, J. J. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.11.002 · Cited by 168
p53 Binds and Activates the Xeroderma Pigmentosum DDB2 Gene in Humans but Not Mice
Tan, T., & Chu, G. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3247-3254.2002 · Cited by 167
Analyses of p53 Target Genes in the Human Genome by Bioinformatic and Microarray Approaches
Wang, L., Wu, Q. J., Qiu, P., Mirza, A., McGuirk, M., Kirschmeier, P. T., Greene, J. R., Wang, Y., Pickett, C. B., & Liu, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106570200 · Cited by 165
Shou, J., Ali‐Osman, F., Multani, A. S., Pathak, S., Fedi, P., & Srivenugopal, K. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205138 · Cited by 164
Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53
Mori, T., Anazawa, Y., Iiizumi, M., Fukuda, S., Nakamura, Y., & Arakawa, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205459 · Cited by 164
Apoptotic threshold is lowered by p53 transactivation of caspase-6
MacLachlan, T. K., & El‐Deiry, W. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132241599 · Cited by 162
Transcriptional Repression by p53 through Direct Binding to a Novel DNA Element
Johnson, R. A., Ince, T. A., & Scotto, K. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100121200 · Cited by 158
Ohlsson, C., Kley, N., Werner, H., & LeRoith, D. (1998) · Endocrinology · doi:10.1210/endo.139.3.5832 · Cited by 157
Bourdon, J., Chambon, V., Lelong, J., Dessen, P., May, P., Debuire, B., & May, E. (1997) · Oncogene · doi:10.1038/sj.onc.1200804 · Cited by 156
Harms, K. L., & Chen, X. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4397 · Cited by 156
Interaction of p53 with Its Consensus DNA-Binding Site
Wang, Y., Schwedes, J. F., Parks, D., Mann, K., & Tegtmeyer, P. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.4.2157 · Cited by 155
p53 Negatively Regulates cdc2 Transcription via the CCAAT-binding NF-Y Transcription Factor
Yun, J., Chae, H., Choy, H. E., Chung, J., Yoo, H., Han, M.-H., & Shin, D. Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.29677 · Cited by 155
Golubovskaya, V., Kaur, A. S., & Cance, W. G. (2004) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2004.03.002 · Cited by 152
The expression of the KAI1 gene, a tumor metastasis suppressor, is directly activated by p53
Mashimo, T., Watabe, M., Hirota, S., Hosobe, S., Miura, K., Tegtmeyer, P., Rinker-Schaeffer, C. W., & Watabe, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11307 · Cited by 150
McKinney, K. M., & Prives, C. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.19.6797-6808.2002 · Cited by 149
Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis
Dohn, M. R., Jiang, J., & Chen, X. (2001) · Oncogene · doi:10.1038/sj.onc.1204816 · Cited by 147
Kunz, C., Pebler, S., Otte, J., & von der Ahe, D. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.18.3710 · Cited by 145
p53 Suppresses the Activation of the Bcl-2 Promoter by the Brn-3a POU Family Transcription Factor
Budhram-Mahadeo, V., Morris, P. J., Smith, M. D., Midgley, C. A., Boxer, L. M., & Latchman, D. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.15237 · Cited by 144
Differential Recognition of Response Elements Determines Target Gene Specificity forp53 and p63
Osada, M., Park, H. L., Nagakawa, Y., Yamashita, K., Fomenkov, A. I., Kim, M. S., Wu, G., Nomoto, S., Trink, B., & Sidransky, D. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.6077-6089.2005 · Cited by 140
Herzer, K., Falk, C. S., Encke, J., Eichhorst, S. T., Ulsenheimer, A., Seliger, B., & Krammer, P. H. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8299-8309.2003 · Cited by 134
Passer, B. J., Nancy-Portebois, V., Amzallag, N., Prieur, S., Cans, C., de Climens, A. R., Fiucci, G., Bouvard, V., Tuynder, M., Susini, L., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530298100 · Cited by 134
Negative regulation of Rb expression by the p53 gene product.
Shiio, Y., Yamamoto, T., & Yamaguchi, N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5206 · Cited by 133
Thornborrow, E. C., Patel, S., Mastropietro, A. E., Schwartzfarb, E. M., & Manfredi, J. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205069 · Cited by 132
Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53.
Morris, G. F., Bischoff, J. R., & Mathews, M. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.895 · Cited by 131
p53 oligomerization and DNA looping are linked with transcriptional activation.
Stenger, J. E., Tegtmeyer, P., Mayr, G. A., Reed, M. J., Wang, Y., Wang, P., Hough, P. V. C., & Mastrangelo, I. A. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06947.x · Cited by 130
Dual-specificity phosphatase 5 (DUSP5) as a direct transcriptional target of tumor suppressor p53
Ueda, K., Arakawa, H., & Nakamura, Y. (2003) · Oncogene · doi:10.1038/sj.onc.1206845 · Cited by 125
p53 tumor suppressor protein regulates the levels of huntingtin gene expression
Feng, Z., Jin, S. V., Zupnick, A., Hoh, J., de Stanchina, E., Lowe, S. W., Prives, C. L., & Levine, A. J. (2005) · Oncogene · doi:10.1038/sj.onc.1209021 · Cited by 125
Self-citationIdentification of Novel p53 Target Genes in Ionizing Radiation Response
Jen, K., & Cheung, V. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1039 · Cited by 119
Maruyama, R., Aoki, F., Toyota, M., Sasaki, Y., Akashi, H., Mita, H., Suzuki, H., Akino, K., Ohe-Toyota, M., Maruyama, Y., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2562 · Cited by 114
Farmer, G., Colgan, J. D., Nakatani, Y., Manley, J. L., & Prives, C. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4295 · Cited by 113
Chen, J., & Sadowski, I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407069102 · Cited by 111
Scherer, S. J., Maier, S. M., Seifert, M., Hanselmann, R. G., Zang, K. D., Müller‐Hermelink, H. K., Angel, P. E., Welter, C., & Schartl, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006990200 · Cited by 107
Han, H. J. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.6.1039 · Cited by 106
Profile of gene expression regulated by induced p53: connection to the TGF‐β family
Kannan, K., Amariglio, N., Rechavi, G., & Givol, D. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01291-6 · Cited by 104
p53 Regulates Caveolin Gene Transcription, Cell Cholesterol, and Growth by a Novel Mechanism
Bist, A., Fielding, C. J., & Fielding, P. E. (2000) · Biochemistry · doi:10.1021/bi991721h · Cited by 104
The Phosphatase MKP1 Is a Transcriptional Target of p53 Involved in Cell Cycle Regulation
Li, M., Zhou, J.-Y., Ge, Y., Matherly, L. H., & Wu, G. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307149200 · Cited by 103
Zhu, J., & Chen, X. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5602-5618.2000 · Cited by 99
Direct Transcriptional Activation of Human Caspase-1 by Tumor Suppressor p53
Gupta, S., Radha, V., Furukawa, Y., & Swarup, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100025200 · Cited by 98
Ori, A., Zauberman, A., Doitsh, G., Paran, N., Oren, M., & Shaul, Y. (1998) · The EMBO Journal · doi:10.1093/emboj/17.2.544 · Cited by 97
p73 is transcriptionally regulated by DNA damage, p53, and p73
Chen, X., Zheng, Y., Zhu, J., Jiang, J., & Wang, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204149 · Cited by 96
Yoon, H., Liyanarachchi, S., Wright, F. A., Davuluri, R. V., Lockman, J. C., de la Chapelle, A., & Pellegata, N. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242597299 · Cited by 95
Decoy Receptor 2 ( DcR2 ) Is a p53 Target Gene and Regulates Chemosensitivity
Liu, X., Yue, P., Khuri, F. R., & Sun, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0939 · Cited by 95
Jung, M.-S., Yun, J., Chae, H., Kim, J., Kim, S., Choi, T.-S., & Shin, D. Y. (2001) · Oncogene · doi:10.1038/sj.onc.1204748 · Cited by 93
p53-mediated repression of DNA methyltransferase 1 expression by specific DNA binding.
Peterson, E. J., Bögler, O., & Taylor, S. M. (2003) · PubMed · Cited by 92
Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells
Obad, S., Brunnström, H., Vallon-Christersson, J., Borg, Å., Drott, K., & Gullberg, U. (2004) · Oncogene · doi:10.1038/sj.onc.1207524 · Cited by 90
p53 is a NF‐Y‐ and p21‐independent, Sp1‐dependent repressor of cyclin B1 transcription
Innocente, S. A., & Lee, J. M. (2005) · FEBS Letters · doi:10.1016/j.febslet.2004.12.073 · Cited by 86
Harmes, D. C., Bresnick, E., Lubin, E. A., Watson, J. K., Heim, K. E., Curtin, J. C., Suskind, A. M., Lamb, J., & DiRenzo, J. (2003) · Oncogene · doi:10.1038/sj.onc.1207129 · Cited by 85
A Genomic Map of p53 Binding Sites Identifies Novel p53 Targets Involved in an Apoptotic Network
Miled, C., Pontoglio, M., Garbay, S., Yaniv, M., & Weitzman, J. B. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4232 · Cited by 85
Thornborrow, E. C., & Manfredi, J. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011643200 · Cited by 85
Cloning of P2XM, a novel human P2X receptor gene regulated by p53.
Urano, T., Nishimori, H., Han, H., Furuhata, T., Kimura, Y., Nakamura, Y., & Tokino, T. (1997) · PubMed · Cited by 83
Zhang, C., Gao, C., Kawauchi, J., Hashimoto, Y., Tsuchida, N., & Kitajima, S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02382-3 · Cited by 81
Shin, T. H., Paterson, A. J., & Kudlow, J. E. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.4694 · Cited by 78
Mortensen, K., Skouv, J., HOUGAARD, D. M., & Larsson, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.37679 · Cited by 78
Saigusa, K., Imoto, I., Tanikawa, C., Aoyagi, M., Ohno, K., Nakamura, Y., & Inazawa, J. (2006) · Oncogene · doi:10.1038/sj.onc.1210148 · Cited by 77
Basile, V., Mantovani, R., & Imbriano, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507712200 · Cited by 77
BLIMP1 regulates cell growth through repression of p53 transcription
Yan, J., Jiang, J., Lim, C. A., Wu, Q., Ng, H., & Chin, K.-C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605562104 · Cited by 75
Identification of SCN3B as a novel p53-inducible proapoptotic gene
Adachi, K., Toyota, M., Sasaki, Y., Yamashita, T., Ishida, S., Ohe-Toyota, M., Maruyama, R., Hinoda, Y., Saito, T., Imai, K., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1208067 · Cited by 74
Proteomics for the early detection and treatment of hepatocellular carcinoma
Feng, J.-T., Shang, S., & Beretta, L. (2006) · Oncogene · doi:10.1038/sj.onc.1209551 · Cited by 74
Farmer, G. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.21.4281 · Cited by 74
Duriez, C., Falette, N., Audoynaud, C., Moyret-Lalle, C., Bensaad, K., Courtois, S., Wang, Q., Soussi, T., & Puisieux, A. (2002) · Gene · doi:10.1016/s0378-1119(01)00825-3 · Cited by 73
Rozenfeld-Granot, G., Krishnamurthy, J., Kannan, K., Toren, A., Amariglio, N., Givol, D., & Rechavi, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205218 · Cited by 72
p53CSV, a Novel p53-Inducible Gene Involved in the p53-Dependent Cell-Survival Pathway
Park, W.-R., & Nakamura, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3339 · Cited by 72
Koutsodontis, G., Vasilaki, E., Chou, W., Papakosta, P., & Kardassis, D. (2005) · Biochemical Journal · doi:10.1042/bj20041980 · Cited by 70
p53 negatively regulates the expression of FAT10, a gene upregulated in various cancers
Zhang, D. W., Jeang, K.-T., & Lee, C. G. L. (2006) · Oncogene · doi:10.1038/sj.onc.1209220 · Cited by 70
Transcriptional activation of the human S100A2 promoter by wild‐type p53
Tan, M., Heizmann, C. W., Guan, K., Schäfer, B. W., & Sun, Y. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00135-0 · Cited by 70
Caspase-1 activator Ipaf is a p53-inducible gene involved in apoptosis
Sadasivam, S., Gupta, S., Radha, V., Batta, K., Kundu, T. K., & Swarup, G. (2004) · Oncogene · doi:10.1038/sj.onc.1208201 · Cited by 65
p53 and Apoptosis: It's Not Just in the Nucleus Anymore
Manfredi, J. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00106-0 · Cited by 63
Warnick, C. T., Dabbas, B., Ford, C. D., & Strait, K. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103088200 · Cited by 61
Transcriptional Regulation of Mitotic Checkpoint Gene MAD1 by p53
Chun, A. C. S., & Jin, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307185200 · Cited by 60
Divergent Regulation of the Growth-promoting GeneIEX-1 by the p53 Tumor Suppressor and Sp1
Im, H., Pittelkow, M. R., & Kumar, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109414200 · Cited by 58
Repression of hsp90β Gene by p53 in UV Irradiation-induced Apoptosis of Jurkat Cells
Zhang, Y., Wang, J., Chen, L., Zhang, Y., Cheng, X.-K., Heng, F.-Y., Wu, N., & Shen, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314213200 · Cited by 58
Dynamics of the p53 Acetylation Pathway
Gu, W., Luo, J., Brooks, C. L., Nikolaev, A. Y., & Li, M. (2004) · Novartis Foundation symposium · doi:10.1002/0470862637.ch14 · Cited by 57
Identification of fractalkine, a CX3C-type chemokine, as a direct target of p53.
Shiraishi, K., Fukuda, S., Mori, T., Matsuda, K., Yamaguchi, T., Tanikawa, C., Ogawa, M., Nakamura, Y., & Arakawa, H. (2000) · PubMed · Cited by 57
The second intron of the human galectin‐3 gene has a strong promoter activity down‐regulated by p53
Raimond, J., Rouleux‐Bonnin, F., Monsigny, M. L. P., & Legrand, A. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00310-6 · Cited by 57
Sun, Y., Zeng, X., Wenger, L., Firestein, G. S., & Cheung, H. S. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20044 · Cited by 57
Hearnes, J. M., Mays, D. J., Schavolt, K. L., Tang, L., Jiang, X. J., & Pietenpol, J. A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.22.10148-10158.2005 · Cited by 57
AMID is a p53-inducible gene downregulated in tumors
Wu, M., Xu, L., Su, T., Tian, Y., Zhai, Z., & Shu, H. (2004) · Oncogene · doi:10.1038/sj.onc.1207909 · Cited by 56
p53RFP, a p53-inducible RING-finger protein, regulates the stability of p21WAF1
Ng, C.-C., Arakawa, H., Fukuda, S., Kondoh, H., & Nakamura, Y. (2003) · Oncogene · doi:10.1038/sj.onc.1206586 · Cited by 54
Prats, A., & Prats, H. (2002) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(02)72075-8 · Cited by 53
Benoît, V., Hellin, A., Huygen, S., GIELEN, J. E., Bours, V., & Merville, M.-P. (2000) · Oncogene · doi:10.1038/sj.onc.1203831 · Cited by 52
Margalit, O., Amram, H. W., Amariglio, N., Simon, A. J., Shaklai, S., Granot, G., Minsky, N., Shimoni, A., Harmelin, A., Givol, D., et al. (2005) · Blood · doi:10.1182/blood-2005-04-1629 · Cited by 52
Regulation of the c-met Proto-oncogene Promoter by p53
Seol, D., Chen, Q., Smith, M. L., & Zarnegar, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.6.3565 · Cited by 51
Kato, M. V., Sato, H., Nagayoshi, M., & Ikawa, Y. (1997) · Blood · doi:10.1182/blood.v90.4.1373 · Cited by 51
p53 Represses CAAT Enhancer-binding Protein (C/EBP)-dependent Transcription of the Albumin Gene
Kubicka, S., Kühnel, F., Zender, L., Rudolph, K. L., Plümpe, J., Manns, M. P., & Trautwein, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32137 · Cited by 50
Jaiswal, A. S., & Narayan, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101298200 · Cited by 50
Britschgi, C., Rizzi, M., Grob, T. J., Tschan, M. P., Hügli, B., Reddy, V. A., Andres, A. ‐., Torbett, B. E., Tobler, A., & Fey, M. F. (2005) · Oncogene · doi:10.1038/sj.onc.1209240 · Cited by 50
Rollwagen, F. M., Yu, Z.-Y., Li, Y., & Pacheco, N. D. (1998) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1998.4600 · Cited by 49
Multiple response elements and differential p53 binding control Perp expression during apoptosis.
Reczek, E. E., Flores, E. R., Tsay, A. S., Attardi, L. D., & Jacks, T. (2003) · PubMed · Cited by 49
Cyclin K as a Direct Transcriptional Target of the p53 Tumor Suppressor
Mori, T., Anazawa, Y., Matsui, K., Fukuda, S., Nakamura, Y., & Arakawa, H. (2002) · Neoplasia · doi:10.1038/sj.neo.7900235 · Cited by 48
Repression of New p53 Targets Revealed by ChIP on Chip Experiments
Ceribelli, M., Alcalay, M., Viganò, M., & Mantovani, R. (2006) · Cell Cycle · doi:10.4161/cc.5.10.2777 · Cited by 48
Matsui, T., Katsuno, Y., Inoue, T., Fujita, F., Joh, T., Niida, H., Murakami, H., Itoh, M., & Nakanishi, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403232200 · Cited by 47
Caspase 10 Levels are Increased Following DNA Damage in a p53-Dependent Manner
Rikhof, B., Corn, P. G., & El‐Deiry, W. S. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.6.626 · Cited by 43
Receptor protein tyrosine kinase DDR is up‐regulated by p53 protein
Sakuma, S., Saya, H., Tada, M., Nakao, M., Fujiwara, T., Roth, J. A., Sawamura, Y., Shinohe, Y., & Abe, H. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01234-3 · Cited by 39
The Bradykinin Type 2 Receptor Is a Target for p53-mediated Transcriptional Activation
Saifudeen, Z. R., Du, H., Dipp, S., & El-Dahr, S. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909810199 · Cited by 38
E2FBP1/DRIL1, an AT-rich interaction domain-family transcription factor, is regulated by p53.
Ma, K., Araki, K., Ichwan, S. J. A., Suganuma, T., Tamamori‐Adachi, M., & Ikeda, M. (2003) · PubMed · Cited by 38
Down-regulation of fibronectin gene expression by the p53 tumor suppressor protein.
Iotsova, V., & Stéhelin, D. (1996) · PubMed · Cited by 35
Kimura, Y., Furuhata, T., Urano, T., Hirata, K., Nakamura, Y., & Tokino, T. (1997) · Genomics · doi:10.1006/geno.1997.4680 · Cited by 31
Wild-Type But Not Mutant p53 Activates the Hepatocyte Growth Factor/Scatter Factor Promoter
Metcalfe, A. M. J., Dixon, R. M., & Radda, G. K. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.5.983 · Cited by 29
Chambon, V., Vacher, M., Jullien, M., May, E., & Bourdon, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203960 · Cited by 28
P53 Activates Fanconi Anemia Group C Gene Expression
Liebetrau, W., Budde, A., Savoia, A., Grummt, F., & Hoehn, H. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.2.277 · Cited by 27
Cytoplasmic complex of p53 and eEF2
Yin, X., Fontoura, B. M. A., Morimoto, T., & Carroll, R. B. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10329 · Cited by 26
Structure and Chromosomal Assignment of the Human Cyclin G Gene
Endo, Y., Fujita, T., Tamura, K., Tsuruga, H., & Nojima, H. (1996) · Genomics · doi:10.1006/geno.1996.0598 · Cited by 23
Wild-type p53 activates SAP expression in lymphoid cells
Nagy, N., Takahara, M., Nishikawa, J., Bourdon, J., Kis, L. L., Klein, G., & Klein, E. (2004) · Oncogene · doi:10.1038/sj.onc.1207908 · Cited by 22
Atomic force microscopy reveals kinks in the p53 response element DNA
Balagurumoorthy, P., Lindsay, S., & Harrington, R. E. (2002) · Biophysical Chemistry · doi:10.1016/s0301-4622(02)00169-2 · Cited by 22
Brinckmann, R., Kaufmann, O., Reinartz, B., & Dietel, M. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200001)190:1 · Cited by 21
Cook, J. L., Rn, R., Jf, G., Fe, F., Dy, C., & Alam, J. (1995) · PubMed · Cited by 16
The ribosomal 5.8S RNA as a target site for p53 protein in cell differentiation and oncogenesis
Elela, S. A., & Nazar, R. N. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00196-1 · Cited by 14
Transcription repression of a CCAAT-binding transcription factor CBF/HSP70 by p53
Chae, H., Yun, J., & Shi, D. Y. (2005) · Experimental & Molecular Medicine · doi:10.1038/emm.2005.60 · Cited by 14
Flagged first, then by citations
Cited by
Sorted by citations
The DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092
The DNA Damage Response: Making It Safe to Play with Knives
Ciccia, A., & Elledge, S. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.019 · Cited by 4,368
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
TP53 mutations in human cancers: origins, consequences, and clinical use.
Olivier, M., Hollstein, M., & Hainaut, P. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001008 · Cited by 2,199
Self-consumption: the interplay of autophagy and apoptosis
Mariño, G., Niso-Santano, M., Baehrecke, E. H., & Kroemer, G. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3735 · Cited by 2,172
Metadata
- Authors
- Riley, T., Sontag, E., Chen, P., & Levine, A.
- Affiliations
- Institute for Advanced Study (US)
- Rutgers, The State University of New Jersey (US)
- Corresponding author
- Riley, Todd
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2008-05
- Volume
- 9
- Issue
- 5
- Pages
- 402-412
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1964719993
- Cited by
- 1,921
- References
- 201
- Citations by year
- 2026: 36 · 2025: 45 · 2024: 56 · 2023: 73 · 2022: 85 · 2021: 97 · 2020: 79 · 2019: 92 · 2018: 110 · 2017: 134 · 2016: 131 · 2015: 115 · 2014: 154 · 2013: 143 · 2012: 153
- FWCI
- 12.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- p53, transcriptional regulation, p53 target genes, DNA damage response, DNA repair, cell cycle arrest, senescence, apoptosis, tumor suppression, transcription factor binding sites, stress signaling
- MeSH terms
- Base Sequence, Binding Sites, Cell Transformation, Neoplastic, DNA Damage, Gene Expression Regulation, Humans, Markov Chains, Molecular Sequence Data, Regulatory Sequences, Nucleic Acid, Transcription, Genetic, Signal Transduction, Genes, p53, Tumor Suppressor Protein p53, Response Elements, Regulatory Elements, Transcriptional
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review